Claritev (CTEV) AI Stock Analysis

• Market Cap: $655.32M
• Dividend Yield: N/A
• Average Volume (3M): 146.90K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.75
• Revenue Growth: -3.33%
• EPS Growth: -86.58%
• Country: US
• Employees: 2,700
• Sector: Healthcare
• Sector Strength: 38
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -4.38
• Shares Outstanding: 16,436,369
• 10 Day Avg. Volume: 75,026
• 30 Day Avg. Volume: 146,895
• PEG Ratio: 0.08
• Price to Book (P/B): 16.41
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 103.99
• Enterprise Value/Market Cap: 51.64
• Enterprise Value/Revenue: 9.01
• Enterprise Value/Gross Profit: 49.21
• Enterprise Value/Ebitda: -11.87
• 1Y Price Target: $47.00
• Price Target Upside: 18.45% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 39 Underperform
• Price Target: $36.00 ▼(-9.27%Downside)

Claritev's overall stock score is low, primarily due to its poor financial performance and challenging valuation. The technical analysis also points to bearish conditions, further weighing on the score. Significant financial challenges and a negative P/E ratio are the most impactful factors.

Claritev Business Overview & Revenue Model

Company Description

Claritev (CTEV) is a technology-driven company specializing in innovative solutions for the telecommunications and data management sectors. The company focuses on providing cutting-edge software applications and platforms that enhance communication efficiency, streamline data processing, and improve overall operational productivity for businesses. With a commitment to leveraging advanced technologies such as artificial intelligence and cloud computing, Claritev aims to empower organizations to optimize their workflows and enhance customer engagement through its robust suite of products and services.

How the Company Makes Money

Claritev generates revenue primarily through a subscription-based model for its software applications, offering tiered pricing plans based on the features and services utilized by its clients. Additionally, the company earns income through implementation services, where it assists businesses in integrating its solutions into their existing systems. Claritev also engages in strategic partnerships with telecommunications providers and technology firms to expand its market reach, which contributes to its revenue through joint ventures and co-branded product offerings. Furthermore, the company may earn revenue from consultancy services, providing expert advice and tailored solutions to enhance operational efficiency for its clients.

Claritev Financial Statement Overview

Summary

Claritev faces financial challenges with declining revenue, negative profitability, high leverage, and cash flow issues. The company needs to improve operational efficiency, reduce leverage, and enhance cash flow for sustainable growth and financial stability.

Income Statement

Over the TTM period, the company has experienced a significant decline in profitability, with EBIT and EBITDA margins deeply negative. Revenue has declined slightly by 0.34% from the previous annual report, indicating challenges in sustaining growth. Historical data shows a trend of decreasing revenue and profit margins, making it imperative for the company to address operational inefficiencies and pursue growth initiatives.

Balance Sheet

The company's balance sheet reveals a high level of leverage, with a Debt-to-Equity ratio that has increased significantly due to declining equity. The Equity Ratio has deteriorated to a concerning level of 0.29%. This high leverage poses a financial risk if not managed carefully. The company needs to improve its equity position and manage debt levels to enhance its financial stability.

Cash Flow

The company's cash flow position is challenging, with negative free cash flow in the TTM period. The Operating Cash Flow has decreased significantly, and the Free Cash Flow to Net Income Ratio is negative, indicating cash flow issues. The company needs to focus on improving cash generation from operations and optimizing capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	927.45M	930.62M	961.52M	1.08B	1.12B	937.76M
Gross Profit	687.68M	691.22M	726.06M	875.62M	942.31M	619.09M
EBITDA	-523.35M	-1.01B	651.93M	158.32M	814.99M	192.41M
Net Income	-1.18B	-1.65B	-91.70M	-572.91M	102.08M	-520.56M
Balance Sheet
Total Assets	5.08B	5.15B	6.96B	7.37B	8.22B	8.28B
Cash, Cash Equivalents and Short-Term Investments	23.13M	16.85M	71.55M	334.05M	185.33M	126.75M
Total Debt	4.63B	4.54B	4.57B	4.78B	4.93B	4.61B
Total Liabilities	5.07B	5.07B	5.26B	5.58B	5.88B	5.73B
Stockholders Equity	14.82M	84.02M	1.71B	1.79B	2.34B	2.56B
Cash Flow
Free Cash Flow	-98.60M	-10.51M	62.87M	282.63M	320.10M	306.56M
Operating Cash Flow	27.84M	107.62M	171.72M	372.36M	404.69M	377.37M
Investing Cash Flow	-126.44M	-118.12M	-249.79M	-104.45M	-228.38M	-210.84M
Financing Cash Flow	63.32M	-41.31M	-180.99M	-115.74M	-114.68M	-61.60M

Claritev Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 39.68
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTEV, the sentiment is Negative. The current price of 39.68 is below the 20-day moving average (MA) of 43.50, below the 50-day MA of 40.24, and above the 200-day MA of 22.30, indicating a neutral trend. The MACD of -0.55 indicates Positive momentum. The RSI at 40.72 is Neutral, neither overbought nor oversold. The STOCH value of 32.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CTEV.

Claritev Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NUTX	74 Outperform	$466.63M	7.06	51.65%	―	141.25%	―
HSTM	64 Neutral	$798.54M	41.86	5.40%	0.45%	3.36%	7.51%
HCAT	64 Neutral	$245.00M	―	-19.80%	―	4.88%	37.87%
EVH	58 Neutral	$1.17B	―	-10.99%	―	10.24%	2.63%
Sector *	51 Neutral	$7.35B	0.50	-65.61%	2.47%	15.28%	1.44%
DH	50 Neutral	$547.31M	―	-86.36%	―	-3.04%	-152.59%
CTEV	39 Underperform	$655.32M	―	-198.69%	―	-3.33%	-86.58%

Claritev Corporate Events

Claritev Shareholders Approve Omnibus Incentive Plan Amendment

On April 30, 2025, Claritev Corporation’s stockholders approved an amendment to the 2020 Omnibus Incentive Plan, increasing the shares reserved for issuance by 1,750,000. At the same annual meeting, stockholders elected three Class II directors, ratified PricewaterhouseCoopers LLP as the independent auditor for 2025, and approved executive compensation, indicating strong shareholder support for the company’s governance and strategic decisions.